CLINICAL TRIALS PROFILE FOR APIDRA
✉ Email this page to a colleague
All Clinical Trials for Apidra
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00115570 ↗ | Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents | Completed | Sanofi | Phase 3 | 2005-04-01 | The purpose of this study is to determine if insulin glulisine (Apidra) is as safe and effective a rapid acting insulin as insulin lispro (Humalog) in children and adolescents with type 1 diabetes mellitus. |
NCT00135083 ↗ | Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus | Completed | Sanofi | Phase 3 | 2004-08-01 | The purpose of this study is to show the non-inferiority of insulin glulisine administered with 1 meal versus 2 meals versus 3 daily meals, as measured by the change in hemoglobin A1c (HbA1c), from baseline to study week 24. |
NCT00135096 ↗ | Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin | Completed | Sanofi | Phase 3 | 2004-08-01 | The purpose of this study is to compare the change in weight from baseline to study week 52 in the per-protocol population of pre-meal insulin glulisine (Apidra) versus post-meal Apidra, in patients receiving insulin glargine (Lantus) as basal insulin. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Apidra
Condition Name
Clinical Trial Locations for Apidra
Trials by Country
Clinical Trial Progress for Apidra
Clinical Trial Phase
Clinical Trial Sponsors for Apidra
Sponsor Name